GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Forward Pharma A/S (OTCPK:FWPAY) » Definitions » Institutional Ownership

Forward Pharma A/S (Forward Pharma A/S) Institutional Ownership : 0.07% (As of Apr. 27, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Forward Pharma A/S Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Forward Pharma A/S's institutional ownership is 0.07%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Forward Pharma A/S's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Forward Pharma A/S's Float Percentage Of Total Shares Outstanding is 0.00%.


Forward Pharma A/S Institutional Ownership Historical Data

The historical data trend for Forward Pharma A/S's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Forward Pharma A/S Institutional Ownership Chart

Forward Pharma A/S Historical Data

The historical data trend for Forward Pharma A/S can be seen below:

2022-02-28 2022-03-31 2022-04-30 2022-05-31 2022-06-30 2022-07-31 2022-08-31 2022-09-30 2022-10-31 2022-11-30
Institutional Ownership 0.09 0.09 0.08 0.08 0.08 0.08 0.08 0.07 0.07 0.07

Forward Pharma A/S Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Forward Pharma A/S (Forward Pharma A/S) Business Description

Traded in Other Exchanges
N/A
Address
Ostergade 24A, 1st Floor, Copenhagen, DNK, 1100
Forward Pharma A/S is a biopharmaceutical company that engages in the research and production of medicinal treatments for multiple sclerosis and psoriasis.